This Article  • References  • Full text PDF  • Send to a friend  • Save in My Folder  • Save to citation manager  • Permissions  Citing Articles  • Contact me when this article is cited  Related Content  • Similar articles in JAMA  Social Bookmarking   What's this?

Renate D. Kimbrough, MD; Joseph Ellis Suggs, PhD
Chamblee, Ga

JAMA. 1973;225(12):1532.

	Since this article does not have an abstract, we have provided the first 150 words of the full text PDF and any section headings.

To the Editor.—

With the intensified use of organophosphorous insecticides by the general population and the increasing use of succinylcholine in general as well as in dental surgery, we would like to point out a problem that has come to our attention.

Humans as well as other species have a specific acetylcholinesterase that is present at the cholinergic junctions of the nervous system and can be measured in red blood cells. In addition, pseudocholinesterase, a plasma enzyme, has no known physiological role but is essential for the rapid degradation of succinylcholine, a muscle relaxant. Levels of this enzyme can be depressed as a result of hepatocellular disease, or exposure to anticholinesterase agents such as the organophosphorous pesticides (Parathion, DDVP, Methylparathion, Demeton). A low plasma pseudocholinesterase level will increase sensitivity to succinylcholine, cause prolonged postoperative apnea, and may result in death from respiratory failure.

Pseudocholinesterase catabolizes several drugs used in anesthesia . . . [Full Text PDF of this Article]

CiteULike    Connotea    Del.icio.us    Digg    Reddit    Technorati    Twitter     What's this?